Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Q32 Bio (QTTB) Return on Sales (2018 - 2024)

Q32 Bio (QTTB) has 7 years of Return on Sales data on record, last reported at 0.13% in Q3 2024.

  • For Q3 2024, Return on Sales rose 738.0% year-over-year to 0.13%; the TTM value through Sep 2024 reached 0.13%, up 662.0%, while the annual FY2025 figure was 0.31%, N/A changed from the prior year.
  • Return on Sales reached 0.13% in Q3 2024 per QTTB's latest filing, down from 0.39% in the prior quarter.
  • Across five years, Return on Sales topped out at 115.58% in Q1 2022 and bottomed at 62.33% in Q2 2020.
  • Average Return on Sales over 5 years is 14.66%, with a median of 13.95% recorded in 2021.
  • Peak YoY movement for Return on Sales: skyrocketed 11562bps in 2022, then tumbled -11790bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 30.4% in 2020, then crashed by -38bps to 41.87% in 2021, then rose by 2bps to 41.07% in 2022, then soared by 114bps to 5.67% in 2023, then tumbled by -102bps to 0.13% in 2024.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.13% in Q3 2024, 0.39% in Q2 2024, and 1.19% in Q1 2024.